We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
Certain app store requirements require mobile apps to provide users with the ability to initiate account deletion.
Eversense® NOW is a mobile App that allows the Eversense® users to share their data and information with friends and family. The Eversense® NOW user will be able to monitor the CGM glucose data of up to 10 Eversense® CGM users.
Note: The Eversense® CGM user has the ability to add/remove friends and family from Eversense NOW access to their data at any time.
Remote Monitoring An optional feature that allows you to invite up to 5 friends and family to view your CGM data using Eversense® NOW, a separate mobile app they download to a compatible mobile device.
If you already have an Eversense® account, you do not have to create a new one to use Eversense® NOW.
If you DO NOT already have an Eversense® account
Choose the unit of measure. The unit of measure you choose will apply to all of the Eversense® CGM users whose data you can view. You cannot change the unit of measure once the app is installed unless you delete and reinstall the app.
Note: If you are expecting an invitation and do not see it in your Inbox, check your Spam or Junk folders.
Note: do not use the emailed link with a different email. The email address used for the account must match the one that received the link.
The glucose data is stored in the cloud, not on your mobile device. If you are downloading the App onto a new device, the following data will automatically become available:
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060